Which statement best describes the primary variable in a clinical trial?

• A. The variable capable of providing the most clinically relevant and convincing evidence directly related to the primary objective.
• B. A composite variable formed from multiple measurements to summarize effects.
• C. A surrogate variable chosen to predict clinical benefit.
• D. A simple biomarker that is easy to measure.

Answer: (A)

In a clinical trial, the primary endpoint is the main outcome used to judge whether the intervention achieves its primary objective. It should be a clinically meaningful measure that directly reflects the patient benefit the study aims to demonstrate, so the evidence it provides is convincing and relevant for decision-making. This endpoint is defined before the trial starts, guides sample size and power, and drives the primary analysis because it represents the core question the trial seeks to answer.

Other endpoints like composites can complicate interpretation because they mix several effects, and surrogates are only as good as their validated link to actual clinical benefit. A simple biomarker might be easy to measure but not necessarily show meaningful patient outcomes.